REPORT: Serum Batch 7B-Alpha Status
DATE: 2025-12-05
STATUS: Batch 7B-Alpha stabilization successful. Crystal purity 99.85%. No foreign contaminants detected. Storage temperature maintained at 36 degrees C. Yield efficiency remains within optimal parameters 94.
NOTES: Requires transfer to long-term cryogenic unit C-9 by 2025-12-07. Dr. Aris to supervise transfer and cataloging.
REPORT: Equipment Maintenance Log
DATE: 2025-12-04
STATUS: Primary Gene Sequencer (Unit X-12) underwent scheduled recalibration. All diagnostic parameters are green. Bio-Teleportation Chamber (Unit B-5) micro-vibrational dampeners replaced. Requires 24-hour cool-down period before next use.
NOTES: Maintenance successful. Logged by Technician J. Doe.
CURRENT NEW SUBJECT COUNT: There are **4** new subjects currently in creation/pre-assessment phases.
| Subject ID | Creation Status | Current Progress Metric | Target Date |
|---|---|---|---|
| **023** | **Completed** (Awaiting transfer to E-4) | 100% (Stable) | N/A |
| **024** | Phase II: Cognitive Programming | 65% Complete | 2026-01-15 |
| **025** | Phase I: Initial Stabilization | 40% Complete | 2026-02-01 |
| **026** | **New Entry** (Initiating Stabilization) | 5% Complete | 2026-02-28 |
NOTE: Subject 023's stability index is 100%. All new subjects must maintain a stability index 95% for transfer to designated environments. Tracking reports are updated daily at 0400 hours.